Eric Pauwels Ptc Therapeutics, Inc. (PTCT) insider trading activity

Eric Pauwels is CHIEF BUSINESS OFFICER of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 70,373 shares of PTCT, which is worth approximately $5.3 Million. The most recent transaction as insider was on Dec 19, 2025, when has been sold 20,508 shares (Common Stock) at a price of $77.05 per share, resulting in proceeds of $1,580,141. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 70.4K

3.48% 3M change

3.96% 12M change

Total Value Held $5.3 Million

Eric Pauwels Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 19 2025	SELL Open market or private sale	$1,580,141 $77.05 p/Share	20,508 Reduced 22.57%	70,373 Common Stock
Dec 19 2025	BUY Exercise of conversion of derivative security	$1,032,167 $50.33 p/Share	20,508 Added 18.53%	90,178 Common Stock
Dec 18 2025	SELL Open market or private sale	$240,246 $75.03 p/Share	3,202 Reduced 4.35%	70,373 Common Stock
Dec 18 2025	BUY Exercise of conversion of derivative security	$161,156 $50.33 p/Share	3,202 Added 4.19%	73,204 Common Stock
Dec 17 2025	SELL Open market or private sale	$3,046,326 $75.61 p/Share	40,290 Reduced 36.41%	70,373 Common Stock
Dec 17 2025	BUY Exercise of conversion of derivative security	$2,027,795 $50.33 p/Share	40,290 Added 27.59%	105,734 Common Stock
Sep 08 2025	SELL Open market or private sale	$2,267,465 $56.9 p/Share	39,850 Reduced 35.34%	72,912 Common Stock

Sep 08 2025	BUY Exercise of conversion of derivative security	$710,525 $17.83 p/Share	39,850 Added 34.95%	74,162 Common Stock
Mar 17 2025	SELL Open market or private sale	$385,163 $56.96 p/Share	6,762 Reduced 8.52%	72,640 Common Stock
Mar 14 2025	SELL Open market or private sale	$246,037 $55.19 p/Share	4,458 Reduced 5.32%	79,402 Common Stock
Feb 20 2025	SELL Open market or private sale	$78,538 $50.12 p/Share	1,567 Reduced 1.83%	83,860 Common Stock
Feb 19 2025	SELL Open market or private sale	$69,037 $50.1 p/Share	1,378 Reduced 1.59%	85,427 Common Stock
Jan 08 2025	SELL Open market or private sale	$95,052 $44.5 p/Share	2,136 Reduced 2.4%	86,805 Common Stock
Jan 07 2025	SELL Open market or private sale	$72,498 $45.34 p/Share	1,599 Reduced 1.77%	88,941 Common Stock
Jan 03 2025	BUY Grant, award, or other acquisition	-	22,000 Added 19.55%	90,540 Common Stock
Apr 17 2024	SELL Open market or private sale	$19,785 $25.14 p/Share	787 Reduced 1.15%	67,694 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	-	24,300 Added 26.19%	68,481 Common Stock
Jan 30 2024	SELL Open market or private sale	$9,973 $27.25 p/Share	366 Reduced 0.82%	44,181 Common Stock
Jan 09 2024	SELL Open market or private sale	$59,905 $29.01 p/Share	2,065 Reduced 4.43%	44,547 Common Stock
Jan 08 2024	SELL Open market or private sale	$44,936 $28.64 p/Share	1,569 Reduced 3.26%	46,612 Common Stock
May 22 2023	SELL Open market or private sale	$119,411 $59.32 p/Share	2,013 Reduced 4.06%	47,553 Common Stock
May 19 2023	SELL Open market or private sale	$377,520 $58.96 p/Share	6,403 Reduced 11.44%	49,566 Common Stock
May 18 2023	SELL Open market or private sale	$46,263 $58.71 p/Share	788 Reduced 1.39%	55,969 Common Stock
May 17 2023	SELL Open market or private sale	$470,888 $58.51 p/Share	8,048 Reduced 12.42%	56,757 Common Stock
Apr 18 2023	SELL Open market or private sale	$38,093 $52.04 p/Share	732 Reduced 1.12%	64,805 Common Stock

Eric Pauwels

CHIEF BUSINESS OFFICER

South Plainfield, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Value

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

Operation

Value

Type

News

Receive news related to PTC THERAPEUTICS, INC.

Track Activities on PTCT

Account